Sign in

CIK 0001774857

  • Emerging growth company

Aardvark Therapeutics, Inc.

Sign in to watch
Ticker
AARD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821606367
Phone
+1 858-225-7696
Business address
4370 LA JOLLA VILLAGE DRIVE, SUITE 1050, SAN DIEGO, CA, 92122
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$394,957
in 1 filing, $395K under 10b5-1 plans

Net −$394,957. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Sun Nelson −$395K Reporting owner sold 68% of stake
Date Insider Transaction Shares Price Value Owned after
2026-11-06 Lee Tien-Li Chief Executive Officer Grant or award · Stock Option (right to buy) +203,851 203,851
2026-11-06 Lee Tien-Li Chief Executive Officer Returned to the company · Stock Option (right to buy) −203,851 0
2026-11-06 Lee Tien-Li Chief Executive Officer Grant or award · Stock Option (right to buy) +549,534 549,534
2026-11-06 Lee Tien-Li Chief Executive Officer Returned to the company · Stock Option (right to buy) −549,534 0
2026-11-06 Lee Tien-Li Chief Executive Officer Grant or award · Stock Option (right to buy) +40,566 40,566
2026-11-06 Lee Tien-Li Chief Executive Officer Returned to the company · Stock Option (right to buy) −40,566 0
2026-11-06 Sun Nelson Grant or award · Stock Option (right to buy) +70,549 70,549
2026-11-06 Sun Nelson Returned to the company · Stock Option (right to buy) −70,549 0
2026-11-06 Sun Nelson Grant or award · Stock Option (right to buy) +209,826 209,826
2026-11-06 Sun Nelson Returned to the company · Stock Option (right to buy) −209,826 0
2026-11-06 Sun Nelson Grant or award · Stock Option (right to buy) +23,719 23,719
2026-11-06 Sun Nelson Returned to the company · Stock Option (right to buy) −23,719 0
2026-11-06 Jaiman Manasi Chief Medical Officer Grant or award · Stock Option (right to buy) +70,549 70,549
2026-11-06 Jaiman Manasi Chief Medical Officer Returned to the company · Stock Option (right to buy) −70,549 0
2026-11-06 Jaiman Manasi Chief Medical Officer Grant or award · Stock Option (right to buy) +126,999 126,999
2026-11-06 Jaiman Manasi Chief Medical Officer Returned to the company · Stock Option (right to buy) −126,999 0
2026-11-06 Jaiman Manasi Chief Medical Officer Grant or award · Stock Option (right to buy) +177,012 177,012
2026-11-06 Jaiman Manasi Chief Medical Officer Returned to the company · Stock Option (right to buy) −177,012 0
2026-10-07 Zhang Zhongwei Director Grant or award · Stock Option (right to buy) +127,061 127,061
2026-09-11 Sun Nelson Sale 10b5-1 −62,000 $5.18 $321K 35,475

Page 1 of 4 · 71 trades